From March 1, 2023 to July 27, 2023, the company has repurchased 266,800 shares, representing 0.29% for CAD 0.24 million. With this, the company has completed the repurchase of 296,800 shares, representing 0.33% for CAD 0.26 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 CAD | -2.70% | -2.70% | -13.25% |
1st Jan change | Capi. | |
---|---|---|
-13.25% | 48.59M | |
+18.11% | 229M | |
+4.12% | 215M | |
+32.56% | 174M | |
-28.57% | 121M | |
+23.91% | 114M | |
-50.96% | 100M | |
-3.85% | 86.78M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.